Keros Therapeutics, Inc. (KROS) Earnings
|
Expand Research on KROS
| Next EPS Date | 11/11/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$0.94 | N/A | N/A | $15.42M | N/A | N/A | N/A | ||
| 8/3/26 |
Q226 | -$1.45 | -$1.40 | -$0.05 | N/A | $706.25K | N/A |  | | Details | |
| 5/14/26 |
Q126 | -$1.21 | -$1.03 | -$0.18 | $370K | $1.69M | N/A | | | Details | |
| 5/7/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A | ||
| 5/5/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$1.03 | N/A | N/A | $1.69M | N/A | N/A | N/A |
